Trifluridine/Tipiracil in Previously Treated Metastatic Colorectal Cancer - The ASCO Post
NCCN® Guidelines for Metastatic Colon Cancer Treatment
How does chemo fit into my treatment plan? - Colontown University
FDA OKs Trifluridine/Tipiracil Plus Bevacizumab for mCRC
IJMS | Free Full-Text | Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment
La FDA approuve Lonsurf plus bevacizumab pour le traitement du cancer colorectal métastatique - Colorectal Cancer Canada
Servier : AMM européenne pour LONSURF en association au bevacizumab dans le cancer colorectal métastatique réfractaire | MyPharma Editions
Avastin and Lonsurf for Advanced Colorectal Cancer - NCI
These highlights do not include all the information needed to use LONSURF safely and effectively. See full prescribing information for LONSURF. LONSURF (trifluridine and tipiracil) tablets, for oral use Initial U.S. Approval:
Lonsurf (trifluridine and tipiracil) for the Treatment of Refractory Metastatic Colorectal Cancer - Clinical Trials Arena
PDF) Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
Taiho Oncology et Servier annoncent la publication dans le New England Journal of Medicine des données de l'étude pivot de phase 3 sur l'association trifluridine/tipiracil (LONSURF®) plus bévacizumab chez le patients atteint
Third-Line Treatment for Metastatic Colorectal Cancer | LONSURF® (trifluridine and tipiracil) tablets
Lonsurf® Treatment for Colorectal Cancer - CancerConnect
NEJM on X: "Among patients with metastatic colorectal cancer, treatment with trifluridine–tipiracil plus bevacizumab as third-line therapy resulted in longer overall survival than trifluridine–tipiracil alone (SUNLIGHT trial). https://t.co/C4DZvyiZiD ...
Nanotechnologies for the treatment of colon cancer: From old drugs to new hope - ScienceDirect
NCCN® Guidelines for Metastatic Colon Cancer Treatment
Servier et Taiho Oncology présentent des données sur la survie globale de trifluridine/tipiracil (LONSURF®) en association avec le bevacizumab chez des patients atteints d'un cancer colorectal métastatique réfractaire... | Business Wire
Lonsurf Plus Bevacizumab Approved for Metastatic Colorectal Cancer
LONSURF® (trifluridine and tipiracil) tablets | Previously Treated mCRC Treatment | TAS-102 Efficacy
Benefits & Risks of Treatment | Metastatic Colorectal Cancer (mCRC)| Avastin® (bevacizumab)
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study | British Journal of Cancer
Colorectal cancer drugs market | Nature Reviews Drug Discovery
LONSURF® (trifluridine and tipiracil) tablets | Previously Treated mCRC Treatment | TAS-102 Efficacy
Trifluridine/Tipiracil Combination Misses Mark in Metastatic Colon Cancer | MedPage Today
OncoPrescribe - Write The Perfect Prescription
How to Take LONSURF® (trifluridine and tipiracil) tablets | Helpful Dosage Reminders
